Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers
Clinical trial NCT02290379 · COMPLETED
Trial details
- NCT number
- NCT02290379
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.